Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

AEBP1 Mouse anti-Human, Clone: 590831, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA524267

Catalog No. PIMA524267


Add to cart

Description

Description

In direct ELISAs, no cross-reactivity with recombit mouse ACLP is observed. Reconstitute in sterile PBS to a final concentration of 0.5 mg/mL.

The adipocyte enhancer binding protein 1 is a transcriptional repressor with carboxypeptidase (CP) activity. This protein binds to a regulatory sequence, adipocyte enhancer 1 (AE-1), located in the proximal promoter region of the adipose P2 (aP2) gene, which encodes the adipocyte fatty-acid binding protein. It is characterized as a member of the regulatory B-like CP family. This protein seems to be activated by a novel mechanism, whereby the direct binding of DNA enhances its protease activity. Adipocyte-enhancer binding protein 1 may play a role in differentiated vascular smooth muscle cells.
Specifications

Specifications

AEBP1
Monoclonal
0.2 mg/mL
PBS with 5% trehalose and No Preservative
Q8IUX7
ACLP, AE-binding protein 1, adipocyte enhancer binding protein 1, adipocyte enhancer-binding protein 1, aortic carboxypeptidase-like protein
Mouse
IgG1
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
165
Flow Cytometry
590831
Unconjugated
AEBP1
Lyophilized
AEBP1
Mouse myeloma cell line NS0-derived recombit human ACLP Glu345-Phe1158
Protein A/G
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit